The Global Degenerative Disc Disease Treatment Market is projected to reach USD 34.0 billion by 2024 and rise further towards reaching USD 66.2 billion by 2033 at a CAGR of 7.7%. The rise in the ...
LAS VEGAS, July 20, 2026 /PRNewswire/ -- Recently published Degenerative Disc Disease Market Insights report includes a comprehensive understanding of current treatment practices, degenerative disc ...
SurGenTec has secured US Food and Drug Administration (FDA) clearance for ION-L, a lumbar facet fixation system for treating degenerative disc disease (DDD) patients who have not benefited from ...
Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...
Lumbar Degenerative Disc Disease: Lumbar degenerative disc disease usually starts with a torsional (twisting) injury to the lower back. Online, June 29, 2014 (Newswire.com) - However, the pain is also ...
Gene expression analysis of nucleus pulposus tissues reveals that dasatinib–quercetin treatment alters key pathways, including cell cycle, RNA, and protein regulation, associated with reduced ...
Degenerative scoliosis is an abnormal spinal curve caused by the deterioration of spinal disks and connective tissue. Medications, physical therapy, and surgery can help relieve symptoms. You’re not ...
A clinical trial at Brown University Health to treat chronic low back pain with a one-time, non-surgical injection treatment is seeking to enroll patients in Rhode Island. The trial is testing whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results